BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35964124)

  • 1. Patterns and determinants of adherence to resistance and endurance training during cancer treatment in the Phys-Can RCT.
    Brooke HL; Mazzoni AS; Buffart LM; Berntsen S; Nordin K; Demmelmaier I
    BMC Sports Sci Med Rehabil; 2022 Aug; 14(1):155. PubMed ID: 35964124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Moderators of the Effect of High vs. Low-to-Moderate Intensity Exercise on Cardiorespiratory Fitness During Breast Cancer Treatment - Analyses of a Subsample From the Phys-Can RCT.
    Bjørke ACH; Buffart LM; Raastad T; Demmelmaier I; Stenling A; Nordin K; Berntsen S
    Front Sports Act Living; 2022; 4():902124. PubMed ID: 35903402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise Adherence and Effect of Self-Regulatory Behavior Change Techniques in Patients Undergoing Curative Cancer Treatment: Secondary Analysis from the Phys-Can Randomized Controlled Trial.
    Mazzoni AS; Brooke HL; Berntsen S; Nordin K; Demmelmaier I
    Integr Cancer Ther; 2020; 19():1534735420946834. PubMed ID: 32909467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of the effects of high intensity and low-to-moderate intensity exercise on physical fitness and fatigue in cancer survivors: results of the Resistance and Endurance exercise After ChemoTherapy (REACT) study.
    Kampshoff CS; Chinapaw MJ; Brug J; Twisk JW; Schep G; Nijziel MR; van Mechelen W; Buffart LM
    BMC Med; 2015 Oct; 13():275. PubMed ID: 26515383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effectiveness and cost-effectiveness of high versus low-to-moderate intensity resistance and endurance exercise interventions among cancer survivors.
    Kampshoff CS; van Dongen JM; van Mechelen W; Schep G; Vreugdenhil A; Twisk JWR; Bosmans JE; Brug J; Chinapaw MJM; Buffart LM
    J Cancer Surviv; 2018 Jun; 12(3):417-429. PubMed ID: 29497963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation in and adherence to physical exercise after completion of primary cancer treatment.
    Kampshoff CS; van Mechelen W; Schep G; Nijziel MR; Witlox L; Bosman L; Chinapaw MJ; Brug J; Buffart LM
    Int J Behav Nutr Phys Act; 2016 Sep; 13(1):100. PubMed ID: 27612561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it safe to exercise during oncological treatment? A study of adverse events during endurance and resistance training - data from the Phys-Can study.
    Henriksson A; Johansson B; Radu C; Berntsen S; Igelström H; Nordin K
    Acta Oncol; 2021 Jan; 60(1):96-105. PubMed ID: 33339484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does exercise intensity matter for fatigue during (neo-)adjuvant cancer treatment? The Phys-Can randomized clinical trial.
    Demmelmaier I; Brooke HL; Henriksson A; Mazzoni AS; Bjørke ACH; Igelström H; Ax AK; Sjövall K; Hellbom M; Pingel R; Lindman H; Johansson S; Velikova G; Raastad T; Buffart LM; Åsenlöf P; Aaronson NK; Glimelius B; Nygren P; Johansson B; Börjeson S; Berntsen S; Nordin K
    Scand J Med Sci Sports; 2021 May; 31(5):1144-1159. PubMed ID: 33527488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of different exercise intensities during oncological treatment in the Phys-Can RCT.
    Ax AK; Husberg M; Johansson B; Demmelmaier I; Berntsen S; Sjövall K; Börjeson S; Nordin K; Davidson T
    Acta Oncol; 2023 Apr; 62(4):414-421. PubMed ID: 37074759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term resource utilisation and associated costs of exercise during (neo)adjuvant oncological treatment: the Phys-Can project.
    Ax AK; Husberg M; Johansson B; Demmelmaier I; Berntsen S; Sjövall K; Börjeson S; Nordin K; Davidson T
    Acta Oncol; 2022 Jul; 61(7):888-896. PubMed ID: 35607981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of the Phys-Can RCT.
    Mazzoni AS; Brooke HL; Berntsen S; Nordin K; Demmelmaier I
    BMC Cancer; 2021 Nov; 21(1):1272. PubMed ID: 34823494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise intensity and markers of inflammation during and after (neo-) adjuvant cancer treatment.
    Schauer T; Mazzoni AS; Henriksson A; Demmelmaier I; Berntsen S; Raastad T; Nordin K; Pedersen BK; Christensen JF
    Endocr Relat Cancer; 2021 Mar; 28(3):191-201. PubMed ID: 33608485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term effect of high versus low-to-moderate intensity exercise to optimise health-related quality of life after oncological treatment-results from the Phys-Can project.
    Ax AK; Johansson B; Lyth J; Nordin K; Börjeson S
    Support Care Cancer; 2022 Jul; 30(7):5949-5963. PubMed ID: 35391574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome.
    Berntsen S; Aaronson NK; Buffart L; Börjeson S; Demmelmaier I; Hellbom M; Hojman P; Igelström H; Johansson B; Pingel R; Raastad T; Velikova G; Åsenlöf P; Nordin K
    BMC Cancer; 2017 Mar; 17(1):218. PubMed ID: 28347291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes.
    Alibhai SMH; Papadopoulos E; Durbano S; Tomlinson G; Mina DS; Ritvo P; Sabiston CM; Matthew AG; Chiarotto J; Sidani S; Culos-Reed SN
    Front Oncol; 2022; 12():1033229. PubMed ID: 36578945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of High and Low-To-Moderate Intensity Exercise During (Neo-) Adjuvant Chemotherapy on Muscle Cells, Cardiorespiratory Fitness, and Muscle Function in Women With Breast Cancer: Protocol for a Randomized Controlled Trial.
    Vikmoen O; Wiestad TH; Thormodsen I; Nordin K; Berntsen S; Demmelmaier I; Strandberg E; Raastad T
    JMIR Res Protoc; 2022 Nov; 11(11):e40811. PubMed ID: 36367769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for promoting habitual exercise in people living with and beyond cancer.
    Bourke L; Homer KE; Thaha MA; Steed L; Rosario DJ; Robb KA; Saxton JM; Taylor SJ
    Cochrane Database Syst Rev; 2013 Sep; (9):CD010192. PubMed ID: 24065550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical activity for women with breast cancer after adjuvant therapy.
    Lahart IM; Metsios GS; Nevill AM; Carmichael AR
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011292. PubMed ID: 29376559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical exercise training interventions for children and young adults during and after treatment for childhood cancer.
    Braam KI; van der Torre P; Takken T; Veening MA; van Dulmen-den Broeder E; Kaspers GJ
    Cochrane Database Syst Rev; 2013 Apr; (4):CD008796. PubMed ID: 23633361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention to principles of exercise training: an updated systematic review of randomized controlled trials in cancers other than breast and prostate.
    Bland KA; Neil-Sztramko SE; Zadravec K; Medysky ME; Kong J; Winters-Stone KM; Campbell KL
    BMC Cancer; 2021 Nov; 21(1):1179. PubMed ID: 34740332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.